MedPath
HSA Approval

NEUROBION TABLET

SIN06258P

NEUROBION TABLET

NEUROBION TABLET

June 21, 1991

PROCTER & GAMBLE (SINGAPORE ) PTE LTD

PROCTER & GAMBLE (SINGAPORE) PTE LTD

Regulatory Information

PROCTER & GAMBLE (SINGAPORE ) PTE LTD

PROCTER & GAMBLE (SINGAPORE) PTE LTD

Therapeutic

Pharmacy Only

Formulation Information

TABLET, SUGAR COATED

**Dosage and administration** 1 coated tablet three times daily to treat moderate cases, or to provide interval and follow-up therapy for a course of injections. Neurobion coated tablets are swallowed without chewing with a little liquid with or after meals. The duration of the treatment is determined by the doctor.

ORAL

Medical Information

**Indications** Neurobion is indicated for neurological and other disorders associated with disturbance of metabolic functions influenced by B complex vitamins, including diabetic polyneuropathy, alcoholic peripheral neuritis and post influenzal neuropathies. Neurobion is also recommended for the treatment of neuritis and neuralgia of the spinal nerves, especially facial paresis, cervical syndrome, low back pain, ischialgia.

**Contraindications** Neurobion must not be used in patients hypersensitive to any of the active ingredients or excipients of the product (see ‘Composition’ – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). Neurobion coated tablets are not suitable for the treatment of children due to the high content of active ingredients.

A11DB

维生素B1与维生素B6和/或B12的复方

Manufacturer Information

PROCTER & GAMBLE (SINGAPORE) PTE LTD

P&G Health Austria GmbH Co. OG

Active Ingredients

PYRIDOXINE HCl

200 mg

Pyridoxine

CYANOCOBALAMIN

200 mcg

Vitamin B12

THIAMINE DISULPHIDE

100 mg

Thiamine disulfide

Documents

Package Inserts

07c. Neurobion Tab PI Proposed Clean.pdf

Approved: June 12, 2020

Download
© Copyright 2025. All Rights Reserved by MedPath